Description

FINERENONE

FINERENONE belongs to a class of drugs known as mineralocorticoid receptor (MR) antagonists. It is used to treat patients with chronic renal damage caused by type 2 diabetes. FINERENONE also lowered the occurrence of new-onset heart failure considerably. Chronic renal disease is defined by a gradual kidney function decline over time. Type 2 diabetes occurs when your body cannot maintain normal blood sugar levels.

FINERENONE contains the active substance finerenone. It works by blocking the action of certain hormones (mineralocorticoids) that can damage your kidneys and heart.

To treat your condition effectually, continue using FINERENONE for as long as your doctor has prescribed it. FINERENONE may cause high potassium level (hyperkalaemia), weakness or tiredness, feeling sick (nausea), numbness in the hands and lips, decreased pulse rate, low sodium level (hyponatraemia), tiredness, headache, confusion, muscle weakness, spasms or cramps and high uric acid level (hyperuricaemia) in some cases. Most of these side effects do not necessitate medical attention and will resolve gradually over time. If you are experiencing these side effects regularly, consult your doctor.

If you are allergic to any components in this composition, do not take FINERENONE; if in doubt, check with a healthcare expert. You should not use this medication while pregnant unless your doctor says it is absolutely necessary. You should not breastfeed if you are on this medication; it might harm your child. FINERENONE is not recommended for children younger than 18 years old. Do not stop taking FINERENONE on your own unless your doctor advises you to. Your doctor may make this decision after checking your blood. Inform your doctor if you have hyperkalemia (high potassium level), severe renal illness, liver illness, heart failure, or Addison’s disease (when your body does not generate enough of the hormones ‘cortisol’ and ‘aldosterone’).

Uses of FINERENONE

Chronic kidney disease (CKD)

Medicinal Benefits

FINERENONE contains the active ingredient finerenone. It belongs to a class of drugs known as non-steroidal mineralocorticoid receptor (MR) antagonists. It is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalisation for heart failure in adult patients with chronic kidney disease associated with type 2 diabetes. FINERENONE also lowered the occurrence of new-onset heart failure considerably. It acts by inhibiting the function of specific hormones (mineralocorticoids) that might cause kidney and cardiac damage.

Directions for Use

FINERENONE should be swallowed as a whole with a glass of water. Do not crush, chew, or break the tablets. The doctor determines the dose and duration based on your health condition.

Storage

Store in a cool and dry place away from sunlight.

Side Effects of FINERENONE

• High potassium level (hyperkalaemia)
• Weakness or tiredness
• Feeling sick (nausea)
• Numbness in the hands and lips
• Muscle cramps
• Decreased pulse rate
• Low sodium level (hyponatraemia)
• Tiredness
• Headache
• Confusion
• Muscle weakness, spasms or cramps
• Decrease in how well the kidneys filter blood (glomerular filtration rate decreased)
• High uric acid level (hyperuricaemia)